By Admin at 14 Mar 2017
The usual treatment for metastatic colorectal cancer includes chemotherapy, radiation and surgical resection. Unfortunately, the average survival rate has been only 20-24 months. In a Gateway-funded clinical trial led by Dr. Edward Lin, a survival rate of approximately 94+ months was achieved using a new approach called ADAPT – Activate tumor from Dormancy And Potentiate its Targeting.
By Admin at 7 Mar 2017
Dr. Nelson Chao, the Donald D. and Elizabeth G. Cooke cancer research professor at Duke University School of Medicine, and colleagues recently developed a cancer research clinical trial, with funding from Gateway for Cancer Research, to delve into how and why patient-centric care works, with groundbreaking results.
By Admin at 23 Feb 2017
A new study determined that precision medicine, which involves targeting the genetic abnormalities in an individual’s tumor, helped children with brain cancer.
By Admin at 15 Feb 2017
The benefits of exercise for cancer survivors and early-stage patients are well established. Less clear is whether the benefits extend to people suffering from advanced stages of the disease, but new research presented at the 2017 Gastrointestinal Cancers Symposium in San Francisco, California suggests they do.
By Admin at 6 Feb 2017
Gateway for Cancer Research is proud to once again partner with the NFL Alumni Association and the 2017 Chicago Charity Golf Classic. The event, Swing for Cures, is set for Monday, May 22 at Cog Hill Country Club in Lemont, IL.